Literature DB >> 22722950

Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta.

F Koerber1, U Schulze Uphoff, S Koerber, E Schönau, D Maintz, O Semler.   

Abstract

PURPOSE: Osteogenesis imperfecta (OI) is a rare hereditary disease leading to multiple bone deformities and fractures. In the absence of causal therapy, a symptomatic approach is based on treatment with bisphosphonates and physiotherapy. The clinical and radiological manifestations vary. Therefore, standardization and quantification for an objective comparison, especially during therapy, are required. In this paper, radiological changes of the spine are quantified according to their clinical relevance to define a scoring system that transfers the morphological changes into a single value representing the severity of the disease.
MATERIALS AND METHODS: 268 lateral spine X-rays of 95 patients with OI (median age 5.6 years) were assessed. The findings were classified based on their clinical relevance.
RESULTS: The three criteria, vertebral compression, thoracolumbar kyphosis and deformity type, were quantified in a new grading system. Based on this, a "severity classification" (1 to 5) was defined with implications for diagnostics and treatment. A mathematical formula that takes into account the three criteria and their correlations to clinical relevance, resulting in a "severity score", was developed.
CONCLUSION: "Severity classification" and "severity score" introduce a new concept for a standardized evaluation of spine X-rays in patients with OI. For both scientific and routine purposes, it provides the user with a simple and easy-to-handle tool for assessing and comparing different stages of severity prior to and during therapy with detailed accuracy. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22722950     DOI: 10.1055/s-0032-1312833

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  7 in total

Review 1.  Osteogenesis imperfecta: pathophysiology and treatment.

Authors:  Heike Hoyer-Kuhn; Christian Netzer; Oliver Semler
Journal:  Wien Med Wochenschr       Date:  2015-06-09

2.  Two years' experience with denosumab for children with osteogenesis imperfecta type VI.

Authors:  Heike Hoyer-Kuhn; Christian Netzer; Friederike Koerber; Eckhard Schoenau; Oliver Semler
Journal:  Orphanet J Rare Dis       Date:  2014-09-26       Impact factor: 4.123

Review 3.  Diagnosis of osteoporotic vertebral fractures in children.

Authors:  Fawaz F Alqahtani; Amaka C Offiah
Journal:  Pediatr Radiol       Date:  2018-11-12

4.  Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort.

Authors:  Heike Hoyer-Kuhn; Mirko Rehberg; Christian Netzer; Eckhard Schoenau; Oliver Semler
Journal:  Orphanet J Rare Dis       Date:  2019-09-18       Impact factor: 4.123

5.  Bone morbidity in pediatric acute lymphoblastic leukemia.

Authors:  Moon Bae Ahn; Byung-Kyu Suh
Journal:  Ann Pediatr Endocrinol Metab       Date:  2020-03-31

6.  Diagnosis of vertebral fractures in children: is a simplified algorithm-based qualitative technique reliable?

Authors:  E Adiotomre; L Summers; A Allison; S J Walters; M Digby; P Broadley; I Lang; A C Offiah
Journal:  Pediatr Radiol       Date:  2016-02-22

7.  Safety and efficacy of denosumab in children with osteogenesis imperfect--a first prospective trial.

Authors:  H Hoyer-Kuhn; J Franklin; G Allo; M Kron; C Netzer; P Eysel; B Hero; E Schoenau; O Semler
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-03       Impact factor: 2.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.